Alanoud Alkhamali

Dr. Alanoud Alkhamali


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KSKarema Mohamed Soliman
Karema Mohamed Soliman
MAMohammed D. Al-Rekabi
Mohammed D. Al-Rekabi
AAAshwaq Najemaldeen Abbas
Ashwaq Najemaldeen Abbas
ADAlshaymaa Darwish
Alshaymaa Darwish
AHAhmed Mohsen Hamdan
Ahmed Mohsen Hamdan
AGAyah M.H. Gowifel
Ayah M.H. Gowifel
There are no curative treatments for Parkinson's disease (PD), and current treatments focus on symptomatic management. This study aimed to investigate the beneficial effects of combining L-DOPA/Carbidopa with essential cofactors (vitamin (VIT) B complex and coenzyme Q10 (CoQ10)), alone or in conjunction with vinpocetine (VIN) or cocoa, as a potential strategy to enhance neuroprotection in rotenone (RT)-induced PD rat model, highlighting mechanistic insights into their underlying neuroprotective mechanisms and focusing on addressing oxidative stress, inflammation, autophagy, and apoptosis. These combinations were tested on adult male Wistar rats allocated into six groups. Group I received saline (normal control), while groups II-VI were injected with RT for 19 days to induce PD. Group II received RT alone, group III received daily oral L-DOPA/Carbidopa, and groups IV-VI received L-DOPA/Carbidopa with VIT B complex and CoQ10, either alone (Group IV) or combined with cocoa (Group V) or VIN (Group VI). These treatments markedly improved RT-induced perturbations in locomotor and cognitive outcomes; neurotransmitters' levels; oxidative stress (Nrf2/HO-1, MDA, INOS, SOD and TAC); inflammatory (NF-κB, TNF-α, IL-1β, GFAP and COX-2); neurotrophic (AKT/CREB/BDNF); apoptotic (BAX, caspase-3, AIF, and Bcl-2); and autophagic (AMPK/SIRT-1/Beclin-1) biomarkers; histopathological findings and tyrosine hydroxylase (TH) immunoexpression. Furthermore, the best outcomes were observed in cocoa and VIN combinations. These results indicated that combining L-DOPA with CoQ10 and VIT B complex in conjunction with either VIN or cocoa could provide a potential strategy for managing motor impairments and preventing neurodegeneration in PD. The interaction between key signaling pathways, including Nrf2/HO-1, NF-kB, AMPK/SIRT-1, and AKT/GSK-3β/CREB/BDNF, likely mediates this effect. However, further clinical validation is required to assess this approach's real-world applicability and therapeutic potential.

28 April 2025 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
AHAhmed Mohsen Hamdan
Ahmed Mohsen Hamdan
HMHebatallah Ahmed Mohamed Moustafa
Hebatallah Ahmed Mohamed Moustafa
MWMing Ming Wen
Ming Ming Wen
MAMohamed AbdElrahman
Mohamed AbdElrahman
AAAlanoud Alkhamali
Alanoud Alkhamali
AKamira B. kassem
amira B. kassem
Background: There is an immense impact of the COVID-19 outbreak on the psychological behavior of healthcare providers due to changing of the working load, financial issues, applying the preventative measures during dealing with the patients, etc. This in turn affects their delivery of the health services. Yet, very few studies have assessed these psychological alterations in community pharmacists. Objective: We aimed to assess the psychological and mental health changes of community pharmacists during COVID-19 early pandemic. Methods: A descriptive cross sectional study questionnaire promoted by both multiple social media platforms and face-to-face interview for community pharmacists in different regions of Alexandria, Egypt between July and September 2021. Results: A total of 1054 community pharmacists (males; 59.8% and females; 40.2%) participated. Young and single pharmacists had significantly high feelings of anxiety, insomnia, and suffering from eating disorders compared with elder and married pharmacists (p < 0.05). Fulltime employed community pharmacists became significantly more nervousness and felt anxious than part-time pharmacists. Female, full-time and less experienced (< 5-year practice) pharmacists had significantly high reports of crying during their working time, and feeling hopeless and uncertain (p < 0.05). Conclusion: COVID-19 has high impact on the mental health of community pharmacists. In the future, regulatory bodies should implement proactive pandemic preparedness programs for sensitive categories of community pharmacists in order to ensure delivering of high quality of essential health services to the community.